サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1730821

クリプトコッカス症の世界市場レポート 2025年

Cryptococcosis Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.37円
クリプトコッカス症の世界市場レポート 2025年
出版日: 2025年05月16日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

クリプトコッカス症市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.2％で、101億7,000万米ドルに成長します。予測期間中の成長は、ヒト免疫不全ウイルス（HIV）/後天性免疫不全症候群（AIDS）と免疫抑制性疾患の有病率の上昇、新規抗真菌療法の採用増加、抗真菌薬の研究開発投資の増加、発展途上地域における医療アクセスの拡大、抗真菌薬の併用療法の出現、感染症対策に対する政府のイニシアチブの高まり、クリプトコッカス感染症に対する意識の高まりに起因すると考えられます。この時期の主要動向としては、次世代抗真菌薬の開発、AIを活用した感染症発生予測分析、ナノテクノロジーを活用したドラッグデリバリーシステム、早期発見のためのウェアラブルバイオセンサ、安全な医薬品サプライチェーンのためのブロックチェーン、真菌感染症モデリングのための3Dバイオプリンティング、抗真菌薬発見における機械学習、クリプトコッカス症治療のための免疫療法の進歩などが挙げられます。

呼吸器感染症の増加はクリプトコッカス症市場の成長を促進すると予想されます。鼻、喉、気道、肺を含む呼吸器系に影響を与える呼吸器感染症は、ウイルス、細菌、真菌によって引き起こされる可能性があります。大気汚染は呼吸器感染症の増加に寄与しています。煙、塵、化学品などの有害な汚染物質が肺機能にダメージを与え、個人が病気にかかりやすくなるからです。免疫力が低下すると、クリプトコッカス症のような日和見感染症が発症しやすい条件が整います。主に肺と中枢神経系を侵すこの真菌感染症は、免疫力の低下した人に重大なリスクをもたらします。例えば、2024年12月、オーストラリア統計局は、インフルエンザに関連した死亡者数の増加を報告しており、2022年の427人に対し、2024年には951人が死亡しています。その結果、呼吸器感染症の罹患率の増加がクリプトコッカス症市場の成長を促進しています。

また、ヒト免疫不全ウイルス（HIV）の蔓延もクリプトコッカス症市場の成長を促進すると予測されています。HIVは免疫系を攻撃し、特にCD4細胞を標的とするため、身体が感染症や病気にかかりやすくなります。HIV感染者の増加は、感染と予防に関する認識と教育の欠如が、危険な行動、診断の遅れ、ウイルスの意図しない拡散の高率につながっていることに起因しています。HIVに感染すると免疫力が低下し、クリプトコッカス症を含む日和見感染症にかかりやすくなります。HIV感染者数の増加に伴い、クリプトコッカス感染症のリスクも上昇するため、効果的な治療に対する需要が高まり、市場の成長が促進されます。例えば、2024年10月、英国保健保障庁は、2023年のHIV診断が51%増加し、2022年の3,975件と比較して6,008件の新規症例が発生したと報告しました。したがって、HIVの有病率の上昇がクリプトコッカス症市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のクリプトコッカス症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のクリプトコッカス症市場：成長率分析
  • 世界のクリプトコッカス症市場の実績：規模と成長、2019～2024年
  • 世界のクリプトコッカス症市場の予測：規模と成長、2024～2029年、2034年
  • 世界のクリプトコッカス症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のクリプトコッカス症市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 補助療法
  • 抗真菌薬
  • 世界のクリプトコッカス症市場：診断技術別、実績と予測、2019～2024年、2024～2029年、2034年
  • 培養方法
  • 顕微鏡検査
  • 分子的方法
  • 世界のクリプトコッカス症市場：感染タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 脳クリプトコッカス症
  • 肺クリプトコッカス症
  • 世界のクリプトコッカス症市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • クリニック
  • 在宅ヘルスケア
  • 病院
  • 研究機関
  • 世界のクリプトコッカス症市場、補助療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 免疫療法
  • 手術
  • 支持療法
  • 世界のクリプトコッカス症市場、抗真菌薬のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • アムホテリシンB
  • フルコナゾール
  • イトラコナゾール
  • ボリコナゾール
  • その他のアゾール

第7章 地域別・国別分析

  • 世界のクリプトコッカス症市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のクリプトコッカス症市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • クリプトコッカス症市場：競合情勢
  • クリプトコッカス症市場：企業プロファイル
    • Pfizer Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Abbott Laboratories
    • Gilead Sciences Inc.

第31章 その他の大手企業と革新的企業

  • Asahi Kasei Pharma Corporation
  • Viatris Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Century Pharmaceuticals Ltd.
  • Beijing Lunarsun Pharmaceutical Co. Ltd.
  • PharmaCompass
  • Matinas Biopharma Holdings Inc.
  • LGM Pharma
  • Atom Pharma
  • Brundavan Laboratories Pvt. Ltd.
  • Zeon Health Industries

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • クリプトコッカス症市場、2029年：新たな機会を提供する国
  • クリプトコッカス症市場、2029年：新たな機会を提供するセグメント
  • クリプトコッカス症市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34493

Cryptococcosis is a fungal infection caused by species of Cryptococcus, such as Cryptococcus neoformans and Cryptococcus gattii, which primarily affect the lungs and central nervous system (CNS). It primarily occurs in immunocompromised individuals, including those with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), organ transplant recipients, and patients undergoing immunosuppressive therapy. If untreated, this infection can lead to cryptococcal meningitis, a life-threatening condition.

The main treatment options for cryptococcosis include adjunctive therapies and antifungal drugs. Adjunctive therapies are additional treatments used alongside primary therapy to enhance effectiveness, improve patient outcomes, or manage side effects. Diagnostic techniques for cryptococcosis include culture methods, microscopic examination, and molecular techniques, which are used to diagnose various infections, including cerebral and pulmonary cryptococcosis. The primary end users of these treatments include clinics, home healthcare providers, hospitals, and research institutes.

The cryptococcosis market research report is one of a series of new reports from The Business Research Company that provides cryptococcosis market statistics, including cryptococcosis industry global market size, regional shares, competitors with a cryptococcosis market share, detailed cryptococcosis market segments, market trends and opportunities, and any further data you may need to thrive in the cryptococcosis industry. This cryptococcosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cryptococcosis market size has grown strongly in recent years. It will grow from $6.52 billion in 2024 to $7.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the rising incidence of immunosuppressive conditions, advancements in antifungal therapies, an increase in organ transplant procedures, greater awareness of fungal infections, the development of amphotericin B formulations, the emergence of Cryptococcus gattii outbreaks, the expansion of healthcare infrastructure, and regulatory approvals for antifungal drugs.

The cryptococcosis market size is expected to see strong growth in the next few years. It will grow to $10.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth during the forecast period can be attributed to the rising prevalence of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and immunosuppressive diseases, the increasing adoption of novel antifungal therapies, growing investments in research and development for antifungal drugs, the expansion of healthcare access in developing regions, the emergence of combination antifungal therapies, rising government initiatives for infectious disease control, and increasing awareness of cryptococcal infections. Major trends during this period include the development of next-generation antifungal drugs, AI-driven predictive analytics for infection outbreaks, nanotechnology-based drug delivery systems, wearable biosensors for early detection, blockchain for secure pharmaceutical supply chains, 3D bioprinting for fungal infection modeling, machine learning in antifungal drug discovery, and advancements in immunotherapy for cryptococcosis treatment.

The increasing occurrence of respiratory infections is expected to drive the growth of the cryptococcosis market. Respiratory infections, which impact the respiratory system including the nose, throat, airways, and lungs, can be caused by viruses, bacteria, or fungi. Air pollution is contributing to the rise in respiratory infections, as harmful pollutants such as smoke, dust, and chemicals damage lung function, making individuals more susceptible to diseases. A weakened immune system creates favorable conditions for opportunistic infections such as cryptococcosis to develop. This fungal infection, which primarily affects the lungs and central nervous system, poses significant risks for immunocompromised individuals. For example, in December 2024, the Australian Bureau of Statistics reported an increase in influenza-related deaths, with 951 deaths in 2024 compared to 427 in 2022. As a result, the growing incidence of respiratory infections is fueling the growth of the cryptococcosis market.

The increasing prevalence of human immunodeficiency virus (HIV) is also expected to drive the cryptococcosis market forward. HIV attacks the immune system, particularly targeting CD4 cells, making the body more vulnerable to infections and diseases. The rise in HIV cases is attributed to a lack of awareness and education regarding transmission and prevention, leading to risky behaviors, delayed diagnoses, and a higher rate of unintentional spread of the virus. As HIV weakens the immune system, individuals become more susceptible to opportunistic infections, including cryptococcosis. With the number of HIV cases increasing, the risk of cryptococcal infections rises, leading to greater demand for effective treatments and driving market growth. For instance, in October 2024, the UK Health Security Agency reported that HIV diagnoses increased by 51% in 2023, with 6,008 new cases compared to 3,975 in 2022. Therefore, the rising prevalence of HIV is contributing to the growth of the cryptococcosis market.

Leading companies in the cryptococcosis market are actively conducting clinical trials to improve the safety and effectiveness of antifungal treatments. These trials play a crucial role in assessing new therapies and enhancing treatment outcomes for patients suffering from severe fungal infections. For example, in August 2023, Matinas BioPharma Holdings Inc., a clinical-stage biopharmaceutical company based in the United States, reported promising results from its Phase II EnACT trial, which tested MAT2203 for the treatment of cryptococcal meningitis. MAT2203 is an oral lipid nanocrystal formulation of amphotericin B that targets fungal cell membranes, causing cell death. The trial demonstrated better survival rates among patients and a favorable safety profile, suggesting that MAT2203 could be a groundbreaking treatment for cryptococcosis, including cryptococcal meningitis.

Major players in the cryptococcosis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbott Laboratories, Gilead Sciences Inc., Asahi Kasei Pharma Corporation, Viatris Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories, Century Pharmaceuticals Ltd., Beijing Lunarsun Pharmaceutical Co. Ltd., PharmaCompass, Matinas Biopharma Holdings Inc., LGM Pharma, Atom Pharma, Brundavan Laboratories Pvt. Ltd., Zeon Health Industries, and Amar Healthcare.

North America was the largest region in the cryptococcosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cryptococcosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cryptococcosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cryptococcosis market consists of revenues earned by entities by providing services such as diagnostic testing, antifungal treatment, hospital care, disease management, telemedicine consultations, research and development, clinical trials, patient monitoring, and epidemiological surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cryptococcosis market also includes sales of amphotericin B, flucytosine, fluconazole, and voriconazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cryptococcosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cryptococcosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cryptococcosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cryptococcosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Adjunctive Therapies; Antifungal Drugs
  • 2) By Diagnostic Technique: Culture Methods; Microscopic Examination; Molecular Methods
  • 3) By Infection Type: Cerebral Cryptococcosis; Pulmonary Cryptococcosis
  • 4) By End User: Clinics; Home Healthcare; Hospitals; Research Institutes
  • Subsegments:
  • 1) By Adjunctive Therapies: Immunotherapy; Surgery; Supportive Care
  • 2) By Antifungal Drugs: Amphotericin B; Fluconazole; Itraconazole; Voriconazole; Other Azoles
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Abbott Laboratories; Gilead Sciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cryptococcosis Market Characteristics

3. Cryptococcosis Market Trends And Strategies

4. Cryptococcosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cryptococcosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cryptococcosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cryptococcosis Market Growth Rate Analysis
  • 5.4. Global Cryptococcosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cryptococcosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cryptococcosis Total Addressable Market (TAM)

6. Cryptococcosis Market Segmentation

  • 6.1. Global Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adjunctive Therapies
  • Antifungal Drugs
  • 6.2. Global Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Methods
  • Microscopic Examination
  • Molecular Methods
  • 6.3. Global Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cerebral Cryptococcosis
  • Pulmonary Cryptococcosis
  • 6.4. Global Cryptococcosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics
  • Home Healthcare
  • Hospitals
  • Research Institutes
  • 6.5. Global Cryptococcosis Market, Sub-Segmentation Of Adjunctive Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunotherapy
  • Surgery
  • Supportive Care
  • 6.6. Global Cryptococcosis Market, Sub-Segmentation Of Antifungal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amphotericin B
  • Fluconazole
  • Itraconazole
  • Voriconazole
  • Other Azoles

7. Cryptococcosis Market Regional And Country Analysis

  • 7.1. Global Cryptococcosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cryptococcosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cryptococcosis Market

  • 8.1. Asia-Pacific Cryptococcosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cryptococcosis Market

  • 9.1. China Cryptococcosis Market Overview
  • 9.2. China Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cryptococcosis Market

  • 10.1. India Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cryptococcosis Market

  • 11.1. Japan Cryptococcosis Market Overview
  • 11.2. Japan Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cryptococcosis Market

  • 12.1. Australia Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cryptococcosis Market

  • 13.1. Indonesia Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cryptococcosis Market

  • 14.1. South Korea Cryptococcosis Market Overview
  • 14.2. South Korea Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cryptococcosis Market

  • 15.1. Western Europe Cryptococcosis Market Overview
  • 15.2. Western Europe Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cryptococcosis Market

  • 16.1. UK Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cryptococcosis Market

  • 17.1. Germany Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cryptococcosis Market

  • 18.1. France Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cryptococcosis Market

  • 19.1. Italy Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cryptococcosis Market

  • 20.1. Spain Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cryptococcosis Market

  • 21.1. Eastern Europe Cryptococcosis Market Overview
  • 21.2. Eastern Europe Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cryptococcosis Market

  • 22.1. Russia Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cryptococcosis Market

  • 23.1. North America Cryptococcosis Market Overview
  • 23.2. North America Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cryptococcosis Market

  • 24.1. USA Cryptococcosis Market Overview
  • 24.2. USA Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cryptococcosis Market

  • 25.1. Canada Cryptococcosis Market Overview
  • 25.2. Canada Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cryptococcosis Market

  • 26.1. South America Cryptococcosis Market Overview
  • 26.2. South America Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cryptococcosis Market

  • 27.1. Brazil Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cryptococcosis Market

  • 28.1. Middle East Cryptococcosis Market Overview
  • 28.2. Middle East Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cryptococcosis Market

  • 29.1. Africa Cryptococcosis Market Overview
  • 29.2. Africa Cryptococcosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cryptococcosis Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cryptococcosis Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cryptococcosis Market Competitive Landscape And Company Profiles

  • 30.1. Cryptococcosis Market Competitive Landscape
  • 30.2. Cryptococcosis Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cryptococcosis Market Other Major And Innovative Companies

  • 31.1. Asahi Kasei Pharma Corporation
  • 31.2. Viatris Inc.
  • 31.3. Astellas Pharma Inc.
  • 31.4. Bausch Health Companies Inc.
  • 31.5. Sun Pharmaceutical Industries Ltd.
  • 31.6. Cipla Limited
  • 31.7. Dr. Reddy's Laboratories
  • 31.8. Century Pharmaceuticals Ltd.
  • 31.9. Beijing Lunarsun Pharmaceutical Co. Ltd.
  • 31.10. PharmaCompass
  • 31.11. Matinas Biopharma Holdings Inc.
  • 31.12. LGM Pharma
  • 31.13. Atom Pharma
  • 31.14. Brundavan Laboratories Pvt. Ltd.
  • 31.15. Zeon Health Industries

32. Global Cryptococcosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cryptococcosis Market

34. Recent Developments In The Cryptococcosis Market

35. Cryptococcosis Market High Potential Countries, Segments and Strategies

  • 35.1 Cryptococcosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cryptococcosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cryptococcosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer